Sequoia Financial Advisors LLC Raises Position in Agilent Technologies, Inc. $A

Sequoia Financial Advisors LLC increased its stake in Agilent Technologies, Inc. (NYSE:AFree Report) by 14.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 48,278 shares of the medical research company’s stock after buying an additional 6,041 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Agilent Technologies were worth $6,413,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in A. SHP Wealth Management bought a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $26,000. Core Wealth Advisors LLC purchased a new stake in Agilent Technologies in the fourth quarter worth about $26,000. Navalign LLC bought a new position in shares of Agilent Technologies during the fourth quarter valued at approximately $27,000. Markowski Investments bought a new stake in Agilent Technologies during the 2nd quarter valued at $27,000. Finally, MV Capital Management Inc. purchased a new position in Agilent Technologies in the fourth quarter valued at about $28,000. Institutional investors own 87.41% of the company’s stock.

Insider Activity at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.17% of the stock is currently owned by company insiders.

Agilent Technologies Stock Performance

NYSE:A opened at $146.91 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The company has a 50 day moving average price of $143.71 and a 200 day moving average price of $128.62. The stock has a market capitalization of $41.42 billion, a P/E ratio of 28.92, a PEG ratio of 2.18 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.

Agilent Technologies (NYSE:AGet Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company’s revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have issued reports on A. TD Cowen lifted their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. The Goldman Sachs Group raised their price target on shares of Agilent Technologies from $155.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Stifel Nicolaus lifted their price objective on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Sanford C. Bernstein boosted their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Finally, Morgan Stanley upped their price target on Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $170.33.

Check Out Our Latest Stock Analysis on A

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

Featured Articles

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.